Fe3 Medical (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- March 03, 2016
- Vertical
- Healthcare
- Funding URL
- View Funding Page
- Funding Amount:
- $11,000,000
Company Info
- Founders
- Mark Sieczkarek
- Company Description
- Fe3 has developed a novel transdermal patch for the treatment of iron-deficiency anemia, one of the world's most prevalent micro-nutrient deficiencies. The Fe3 patch offers an alternative to oral iron for the nearly half of patients who cannot tolerate gastrointestinal side effects of iron pills.
- Market
- Iron-deficiency anemia treatment
- Location
- San Antonio, TX, USA
- Coinvestors
- HG Capital, Jianmin Pharmaceuticals, Ping An Ventures